Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income - MinorityNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Cumberland Pharmaceuticals (CPIX) Consolidated Net Income (2016 - 2025)

Cumberland Pharmaceuticals (CPIX) has disclosed Consolidated Net Income for 15 consecutive years, with -$1.4 million as the latest value for Q4 2025.

  • Quarterly Consolidated Net Income rose 25.67% to -$1.4 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$2.9 million through Dec 2025, up 55.77% year-over-year, with the annual reading at -$2.9 million for FY2025, 55.77% up from the prior year.
  • Consolidated Net Income hit -$1.4 million in Q4 2025 for Cumberland Pharmaceuticals, up from -$1.9 million in the prior quarter.
  • In the past five years, Consolidated Net Income ranged from a high of $1.2 million in Q1 2025 to a low of -$6.3 million in Q4 2023.
  • Historically, Consolidated Net Income has averaged -$852144.9 across 4 years, with a median of -$899213.0 in 2023.
  • Biggest five-year swings in Consolidated Net Income: crashed 1204.25% in 2024 and later surged 165.61% in 2025.
  • Year by year, Consolidated Net Income stood at $503318.0 in 2021, then tumbled by 1352.09% to -$6.3 million in 2023, then soared by 69.78% to -$1.9 million in 2024, then increased by 25.67% to -$1.4 million in 2025.
  • Business Quant data shows Consolidated Net Income for CPIX at -$1.4 million in Q4 2025, -$1.9 million in Q3 2025, and -$735207.0 in Q2 2025.